RUNX1 and acute lymphoblastic leukemia: The relapse samples retained the translocation of ETV6‐RUNX1 relative to the three‐way translocation t(8;12;21) at diagnosis, suggesting that the three‐way translocation might be an important risk factor for relapse in patients with ETV6‐RUNX1‐positive ALL and should be further studied.